Covid-19 roundup: J&J shot remains on hold after CDC panel vote
The J&J vaccine will, at least for now, remain on hold.
An advisory convened by the CDC and FDA voted on Wednesday to request more information on the rare but potentially deadly blood-clotting disorder that appeared in six people who received the J&J shot before they decide whether to restrict or fully resume rolling the vaccine out. The decision will keep the vaccine on factory shelves and in pharmacy refrigerators for another week to ten days.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
